Skip to main content
. 2021 Feb 16;82(4):255–263. doi: 10.1016/j.humimm.2021.02.007

Table 2.

Characteristics of patients given CP and those not given CP.

Characteristic All CP Recipients (n = 28) Low titer (</=1:1024) (n = 9) High titer (>1:1024) (n = 19) No CP (n = 17)
Median age (IQR) – yr 67.5 (53.3–75.0) 68.0 (62.0–70.0) 67.0 (53.5–76.5) 62 (56.5–70.0)
Age Category – no. (%)
 < 50 yr 4 (14.3) 1 (11.1) 3 (15.8) 1 (5.9)
 50 to <70 yr 13 (46.4) 5 (55.6) 8 (42.1) 12 (70.6)
 >= 70 yr 11 (39.3) 3 (33.3) 8 (42.1) 4 (23.5)
Sex – no. (%)
 Male 19 (67.9) 5 (55.6) 14 (73.7) 10 (58.8)
 Female 9 (32.1) 4 (44.4) 5 (26.3) 7 (41.2)
Race – no. (%)
 Black 24 (85.7) 6 (66.7) 18 (94.7) 12 (70.6)
 Non-Black 2 (7.1) 2 (22.2) 0 (0) 2 (11.8)
 Undisclosed 2 (7.1) 1 (11.1) 1 (5.3) 3 (17.6)
Median days ill before transfusion (IQR) - days 9 (7–16.5) 12 (9.0–17.0) 8 (5.0–14.5) NA
Received mechanical ventilation (%) 13 (46.4) 6 (66.6) 7 (36.8) 17 (100.0)
Mortality (%) 14 (50.0) 7 (77.8) 7 (36.8) 9 (52.9)
Coexisting conditions - no. (%)
Any condition 22 (78.6) 8 (88.9) 15 (78.9) 16 (94.1)
Hypertension 17 (60.7) 6 (66.6) 11 (57.9) 11 (64.7)
Renal disease 8 (28.6) 3 (33.3) 5 (26.3) 1 (5.9)
Diabetes 7 (25.0) 4 (44.4) 6 (31.6) 11 (64.7)
Respiratory (e.g., asthma, COPD) 7 (25.0) 1 (11.1) 4 (21.1) 2 (11.8)
Hyperlipidemia 4 (14.3) 0 (0.0) 2 (10.5) 0 (0.0)

Keys: COPD – chronic obstructive pulmonary disease; NA – not applicable.